Page 33 - Read Online

myasthenia: “rebooting” with high‑dose cyclophosphamide. Ann antiacetylcholine receptor antibodies in the CSF. Eur Neurol
Neurol 2003;53:29‑34. 1983;22:301‑6.
10. Ponseti JM, Azem J, Fort JM, Codina A, Montoro JB, Armengol M. 27. Anderson NE, Hutchinson DO, Nicholson GJ, Aitcheson F,
Benefits of FK506 (tacrolimus) for residual, cyclosporin‑ and Nixon JM. Intestinal pseudo‑obstruction, myasthenia gravis, and
prednisone‑resistant myasthenia gravis: one‑year follow‑up of an thymoma. Neurology 1996;47:985‑7.
open‑label study. Clin Neurol Neurosurg 2005;107:187‑90. 28. Stoica E, Enulescu O. Deficiency of sympathetic nervous system
11. Chiu HC, Chen WH, Yeh JH. The six year experience of function in myasthenia. J Auton Nerv Syst 1992;38:69‑76.
plasmapheresis in patients with myasthenia gravis. Ther Apher 29. Evoli A, Minicuci GM, Vitaliani R, Battaglia A, Della Marca G,
2000;4:291‑5. Lauriola L, Fattorossi A. Paraneoplastic diseases associated with
12. Wegner B, Ahmed I. Intravenous immunoglobulin monotherapy in thymoma. J Neurol 2007;254:756‑62.
long‑term treatment of myasthenia gravis. Clin Neurol Neurosurg 30. Thorlacius S, Aarli JA, Riise T, Matre R, Johnsen HJ. Associated
2002;105:3‑8. disorders in myasthenia gravis: autoimmune diseases and their
13. Gronseth GS, Barohn RJ. Practice parameter: thymectomy for relation to thymectomy. Acta Neurol Scand 1989;80:290‑5.
autoimmune myasthenia gravis (an evidence‑based review): report 31. Stein PK, Bosner MS, Kleiger RE, Conger BM. Heart rate
of the quality standards subcommittee of the American academy of variability: a measure of cardiac autonomic tone. Am Heart J
neurology. Neurology 2000;55:7‑15. 1994;127:1376‑81.
14. Furlund Owe J, Skulstad Davidsen E, Eide GE, Gerdts E, Gilhus NE. 32. Clinical competence in ambulatory electrocardiography. A statement
Left ventricular long‑axis function in myasthenia gravis. J Neurol for physicians from the ACP/ACC/AHA Task Force on Clinical
2008;255:1777‑84. Privileges in Cardiology. J Am Coll Cardiol 1993;22:331‑5.
15. Ashok PP, Ahuja GK, Manchanda SC, Jalal S. Cardiac involvement 33. Vikman S, Mäkikallio TH, Yli‑Mäyry S, Pikkujämsä S, Koivisto AM,
in myasthenia gravis. Acta Neurol Scand 1983;68:113‑20. Reinikainen P, Airaksinen KE, Huikuri HV. Altered complexity
16. Asensio E, Gómez M, Narváez R, Castillo L, Oseguera J, Dorantes J, and correlation properties of R‑R interval dynamics before the
Orea A, Hernandez P, Rebollar V. Description of the resting spontaneous onset of paroxysmal atrial fibrillation. Circulation
electrocardiogram in a series of patients with myasthenia gravis. 1999;100:2079‑84.
Rev Invest Clin 2003;55:270‑5. 34. Valkama JO, Huikuri HV, Koistinen MJ, Yli‑Mäyry S,
17. Calin C, Savu O, Dumitru D, Ghiorghiu I, Calin A, Capraru C, Airaksinen KE, Myerburg RJ. Relation between heart rate
Popescu BA, Croitoru M, Vilciu C, Ginghina C. Cardiac involvement variability and spontaneous and induced ventricular arrhythmias
in myasthenia gravis ‑ is there a specific pattern? Rom J Intern Med in patients with coronary artery disease. J Am Coll Cardiol
2009;47:179‑89. 1995;25:437‑43.
18. Douchet MP, Quiring E, Bronner F, Vi‑Fane R, Messier M, Chauvin M, 35. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, Heinemann S.
Warter JM. Paradoxal lowering of parasympathetic indices in Alpha 9: an acetylcholine receptor with novel pharmacological
myasthenic patients. Arch Mal Coeur Vaiss 1999;92:711‑7. properties expressed in rat cochlear hair cells. Cell 1994;79:705‑15.
19. Vernino S, Cheshire WP, Lennon VA. Myasthenia gravis 36. Lips KS, Pfeil U, Kummer W. Coexpression of alpha 9 and alpha 10
with autoimmune autonomic neuropathy. Auton Neurosci nicotinic acetylcholine receptors in rat dorsal root ganglion neurons.
2001;88:187‑92. Neuroscience 2002;115:1‑5.
20. de Jongste MJ, Oosterhuis HJ, Lie KI. Intractable ventricular 37. Lewis SW, Ron MA, Newsom‑Davis J. Absence of central functional
tachycardia in a patient with giant cell myocarditis, thymoma and cholinergic deficits in myasthenia gravis. J Neurol Neurosurg
myasthenia gravis. Int J Cardiol 1986;13:374‑8. Psychiatry 1989;52:258‑61.
21. Hofstad H, Ohm OJ, Mørk SJ, Aarli JA. Heart disease in myasthenia 38. Nóbrega AC, dos Reis AF, Moraes RS, Bastos BG, Ferlin EL,
gravis. Acta Neurol Scand 1984;70:176‑84. Ribeiro JP. Enhancement of heart rate variability by cholinergic
22. Suzuki S, Utsugisawa K, Yoshikawa H, Motomura M, Matsubara S, stimulation with pyridostigmine in healthy subjects. Clin Auton Res
Yokoyama K, Nagane Y, Maruta T, Satoh T, Sato H, Kuwana M, 2001;11:11‑7.
Suzuki N. Autoimmune targets of heart and skeletal muscles in 39. Behling A, Moraes RS, Rohde LE, Ferlin EL, Nóbrega AC, Ribeiro JP.
myasthenia gravis. Arch Neurol 2009;66:1334‑8. Cholinergic stimulation with pyridostigmine reduces ventricular
23. Suzuki S, Baba A, Kaida K, Utsugisawa K, Kita Y, Tsugawa J, arrhythmia and enhances heart rate variability in heart failure. Am
Ogawa G, Nagane Y, Kuwana M, Suzuki N. Cardiac involvements Heart J 2003;146:494‑500.
in myasthenia gravis associated with anti‑Kv1.4 antibodies. Eur J 40. Baraka A. Anaesthesia and myasthenia gravis. Can J Anaesth
Neurol 2014;21:223‑30. 1992;39:476‑86.
24. Senda Y, Sugimura K, Koike Y, Matsuoka Y, Takahashi A. 41. Hamed SA. Comorbid nervous system manifestations and disorders
Concurrence of acute autonomic and sensory neuropathy and with myasthenia gravis: Evide nces and possible mechanisms. J
myasthenia gravis ‑ a case report and pathogenetic considerations. Neurol Neurosci 2012;3:2.
Rinsho Shinkeigaku 1989;29:332‑5.
25. Pande R, Leis AA. Myasthenia gravis, thymoma, intestinal
pseudo‑obstruction, and neuronal nicotinic acetylcholine receptor Cite this article as: Hamed SA, Mohamad KO, Adam M. Cardiac autonomic
antibody. Muscle Nerve 1999;22:1600‑2. function in patients with myasthenia gravis: analysis of the heart-rate variability
in the time-domain. Neuroimmunol Neuroinflammation 2015;2(1):21-5.
26. Bogousslavsky J, Regli F, Doret AM, Fulpius BW, Ostinelli B,
Rabinowicz T, Ruzicka J. Encephalopathy, peripheral neuropathy, Source of Support: Nil. Conflict of Interest: No.
dysautonomia, myasthenia gravis, malignant thymoma, and Received: 19-08-2014; Accepted: 30-09-2014

Neuroimmunol Neuroinflammation | Volume 2 | Issue 1 | January 15, 2015 25